11.26 USD
↘ 0.04 (0.39%)PRE MARKET (AS OF 05:07 AM EDT)
Kura Oncology, Inc.
KURANASDAQ • USD
Market: OPEN
Shares of Kura Oncology, Inc. (KURA) are trading at $11.26. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Sep 15, 2026.
Open?$11.52
High?$11.52
Low?$11.26
Prev. Close?$11.30
Volume?56
Avg. Volume?2.1M
VWAP?$11.34
Rel. Volume?0.00x
Bid / Ask
Bid?$9.57 × 100
Ask?$12.93 × 100
Spread?$3.36
Midpoint?$11.25
Valuation & Ratios
Market Cap?1.0B
Shares Out?89.0M
Float?78.2M
Float %?88.1%
P/E Ratio?N/A
P/B Ratio?20.76
EPS?-$3.34
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
Employees
260
Market Cap
1.0B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-08-25
Address
4930 DIRECTORS PLACE, SUITE 500
SAN DIEGO, CA 92121
Phone: (858) 500-8800
SAN DIEGO, CA 92121
Phone: (858) 500-8800
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?0
Momentum?75
Short Sent.?36
Piotroski F-Score?4/9Mixed
Altman Z-Score?-2.77Distress
Confidence?53%Low
Short InterestHigh
Short % of Float?17.16%High
Short Interest?13.4M
Days to Cover?4.8
Free Float78.2M
Avg Daily Volume2.8M
Settlement Date2026-08-31
Financial Health
Current Ratio?4.73Strong
Quick Ratio?4.71Strong
Cash Ratio?0.59Adequate
Debt/Equity?0.20Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?20.76HIGH▾
Peers100
S&P7
P/S?13.02HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-3.0CHEAP▾
S&P97
EV/Sales?12.23HIGH▾
Peers100
S&P7
Returns & Efficiency
ROE?-612.8%WEAK▾
S&P3
ROA?-50.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-117429000
Enterprise Value?$944.8M
Fundamentals ratios updated end of day